QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 0.41
-- x --
-- x --
-- - --
$ 0.35 - $ 0.95
48,233
na
284,587
$ 5.62
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-26-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-10-2023 06-30-2023 10-Q
4 05-04-2023 03-31-2023 10-Q
5 03-16-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 03-24-2022 12-31-2021 10-K
10 11-10-2021 09-30-2021 10-Q
11 08-11-2021 06-30-2021 10-Q
12 05-12-2021 03-31-2021 10-Q
13 03-25-2021 12-31-2020 10-K
14 11-12-2020 09-30-2020 10-Q
15 08-11-2020 06-30-2020 10-Q
16 05-12-2020 03-31-2020 10-Q
17 03-24-2020 12-31-2019 10-K
18 11-13-2019 09-30-2019 10-Q
19 08-13-2019 06-30-2019 10-Q
20 05-14-2019 03-31-2019 10-Q
21 03-22-2019 12-31-2018 10-K
22 11-05-2018 09-30-2018 10-Q
23 08-13-2018 06-30-2018 10-Q
24 05-14-2018 03-31-2018 10-Q
25 03-21-2018 12-31-2017 10-K
26 11-14-2017 09-30-2017 10-Q
27 08-10-2017 06-30-2017 10-Q
28 05-11-2017 03-31-2017 10-Q
29 03-30-2017 12-31-2016 10-K
30 11-10-2016 09-30-2016 10-Q
31 08-11-2016 06-30-2016 10-Q
32 05-12-2016 03-31-2016 10-Q
33 03-08-2016 12-31-2015 10-K
34 11-16-2015 09-30-2015 10-Q
35 08-13-2015 06-30-2015 10-Q
36 05-15-2015 03-31-2015 10-Q
37 03-30-2015 12-31-2014 10-K
38 11-14-2014 09-30-2014 10-Q
39 08-14-2014 06-30-2014 10-Q
40 05-15-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-maintains-buy-on-panbela-therapeutics-lowers-price-target-to-5

HC Wainwright & Co. analyst Joseph Pantginis maintains Panbela Therapeutics (OTC:PBLA) with a Buy and lowers the price t...

 roth-mkm-maintains-buy-on-panbela-therapeutics-maintains-25-price-target

Roth MKM analyst Jonathan Aschoff maintains Panbela Therapeutics (OTC:PBLA) with a Buy and maintains $25 price target.

 panbela-therapeutics-q4-2023-gaap-eps-6590-misses-2434-estimate

Panbela Therapeutics (NASDAQ:PBLA) reported quarterly losses of $(65.90) per share which missed the analyst consensus estimate ...

 top-4-health-care-stocks-that-are-preparing-to-pump-this-month

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

 panbela-regains-nasdaq-compliance
Panbela Regains Nasdaq Compliance
02/15/2024 13:05:07

 roth-mkm-maintains-buy-on-panbela-therapeutics-adjusts-price-target-to-25

Roth MKM analyst Jonathan Aschoff maintains Panbela Therapeutics (NASDAQ:PBLA) with a Buy, adjusts target to $25 from $500.

 whats-going-on-with-panbela-therapeutics-stock-today

Panbela Therapeutics announced acceptance of SBP-101 abstract for presentation and disclosed details of a public offering, expe...

 panbela-therapeutics-announced-abstract-for-sbp-101-accepted-for-poster-presentation-at-american-association-for-cancer-research

Poster PresentationTitle:  Ivospemin/doxorubicin combination modulates polyamine metabolism to improve survival in murine ovari...

 crude-oil-down-over-1-science-37-holdings-shares-spike-higher

U.S. stocks traded slightly higher toward the end of trading, with the Nasdaq Composite gaining around 75 points on Monday. Th...

 why-panbela-therapeutics-shares-are-trading-lower-by-65-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of...

 dow-edges-lower-cardlytics-shares-jump

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 20 points on Monday. The Dow traded ...

 us-stocks-edge-higher-amazon-and-irobot-agree-to-terminate-acquisition-deal

U.S. stocks traded slightly higher this morning, with the Dow Jones index gaining around 25 points on Monday. Following the ma...

 why-zim-integrated-shipping-services-shares-are-trading-higher-by-9-here-are-20-stocks-moving-premarket

ZIM Integrated Shipping Services Ltd. (NYSE: ZIM) shares rose sharply in today's pre-market trading after Jefferies upgrade...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION